Related Experiment Video
Updated: Aug 15, 2025

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Complete revascularization in acute myocardial infarction: a clinical review
Yuichi Saito1, Yoshio Kobayashi2
1Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-Ku, Chiba, Chiba, 260-8677, Japan. saitoyuichi1984@gmail.com.
Insights
Complete revascularization for multivessel (MV) coronary artery disease in myocardial infarction (MI) patients may reduce adverse events. Optimal timing and strategies for MV intervention require further study.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiovascular Medicine
Background:
- Multivessel (MV) coronary artery disease affects ~50% of myocardial infarction (MI) patients, correlating with poorer outcomes.
- Complete revascularization via MV percutaneous coronary intervention shows promise in reducing major adverse cardiovascular events compared to culprit vessel-only treatment.
Purpose of the Study:
- To review current evidence on revascularization strategies for acute MI patients with MV disease.
- To highlight areas needing further investigation, including optimal timing and lesion assessment for MV intervention.
Main Methods:
- Literature review of recent data and evidence on revascularization strategies.
- Synthesis of findings related to complete vs. culprit vessel-only revascularization.
- Identification of knowledge gaps in specific patient subsets like cardiogenic shock.
Main Results:
- Complete MV percutaneous coronary intervention is associated with reduced major adverse cardiovascular events.
- Optimal timing and assessment of non-culprit lesions remain areas for further research.
- Specific strategies for subsets like cardiogenic shock are not yet established.
Conclusions:
- Revascularization strategies for acute MI with MV disease are evolving.
- Further research is crucial to define optimal timing, lesion assessment, and tailored approaches for specific patient groups.
Abstract:
In patients with ST segment elevation and non-ST elevation myocardial infarction (MI), multivessel (MV) coronary artery disease is found in approximately 50%, leading to worse clinical outcomes. Recent data have suggested that complete revascularization with MV percutaneous coronary intervention is associated with a reduced risk of major adverse cardiovascular events as compared to culprit vessel-only revascularization. However, the optimal timing of MV intervention, appropriate non-culprit lesion assessment, and the best revascularization strategy in specific subsets such as cardiogenic shock remain to be established. This review article summarizes current evidence on revascularization strategies in patients with acute MI and MV disease.
More Related Videos
09:21Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Acute Coronary Syndrome V: Nursing Management